These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 33763358)
1. Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas. Liu R; Wang J; Wang N; Li J; Ge X; Zhang J; Ma J Front Oncol; 2021; 11():622847. PubMed ID: 33763358 [No Abstract] [Full Text] [Related]
2. Different serum levels of IgG and complements and recurrence rates in IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion. Liu R; Wang N; Wang JJ; Li J; Ge X; Zhang JX; Ma JM Int J Ophthalmol; 2023; 16(6):876-883. PubMed ID: 37332559 [TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological study on IgG4-related ophthalmic disease involving the lacrimal gland]. Li HQ; Lin JY; Zhao H Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):834-841. PubMed ID: 31715680 [No Abstract] [Full Text] [Related]
5. Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review. Matsuo T; Tanaka T; Notohara K; Okada K J Investig Med High Impact Case Rep; 2022; 10():23247096211067894. PubMed ID: 35038946 [TBL] [Abstract][Full Text] [Related]
6. Clinical research on benign lymphoepithelial lesions of lacrimal gland in 20 Chinese patients. Ma JM; Li J; Ge X; Li M; Li JR; Wang XN Chin Med J (Engl); 2015 Feb; 128(4):493-8. PubMed ID: 25673452 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Efficacy of Immune and Inflammatory Markers in the Diagnosis of Lacrimal-Gland Benign Lymphoepithelial Lesion. Luan F; Liu R; Li J; Ge X; Wang N; Guo Q; Tao Y; Ma J Curr Issues Mol Biol; 2023 Mar; 45(3):2013-2020. PubMed ID: 36975499 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor. Min HK; Lee YS; Yang SW; Lee J; Kwok SK; Ju JH; Kim WU; Park SH Korean J Intern Med; 2019 Jan; 34(1):220-226. PubMed ID: 29050463 [TBL] [Abstract][Full Text] [Related]
9. [A clinicopathological study of IgG4-related ocular disease and differentiated diagnosis with non-IgG4-related ocular disorders]. Wu X; Luo QL; Li GD Zhonghua Yan Ke Za Zhi; 2016 Apr; 52(4):256-62. PubMed ID: 27094062 [TBL] [Abstract][Full Text] [Related]
10. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Takahira M; Goto H; Azumi A Jpn J Ophthalmol; 2024 Jul; 68(4):293-301. PubMed ID: 39037515 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma with IgG4-Positive Cells. Lee MJ; Kim N; Choe JY; Khwarg SI; Jeon YK; Choung HK; Kim JE PLoS One; 2015; 10(6):e0131458. PubMed ID: 26111022 [TBL] [Abstract][Full Text] [Related]
12. Lacrimal Gland and Orbital Lesions in Lat Hamaoka S; Takahira M; Kawano M; Yamada K; Ito K; Okuda T; Hatake S; Malissen M; Malissen B; Sugiyama K Curr Eye Res; 2022 Oct; 47(10):1405-1412. PubMed ID: 35913026 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease. Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis of IgG4 - related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Vasilyev VI; Safonova TN; Socol EV; Probatova NA; Kokosadze NV; Pavlovskaya AI; Kovrigina AM; Radenska-Lopovok SG; Gorodetsky VR; Rodionova EB; Palshina SG; Aleksandrova EN; Shornikova NS; Gaiduk IV Ter Arkh; 2018 May; 90(5):61-71. PubMed ID: 30701891 [TBL] [Abstract][Full Text] [Related]
16. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Liu Y; Xue M; Wang Z; Zeng Q; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li ZG Rheumatology (Oxford); 2020 Mar; 59(3):634-640. PubMed ID: 31436287 [TBL] [Abstract][Full Text] [Related]
17. Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Bledsoe JR; Wallace ZS; Stone JH; Deshpande V; Ferry JA Virchows Arch; 2018 May; 472(5):839-852. PubMed ID: 29285637 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and treatment outcomes of patients with IgG4-positive ocular adnexal marginal zone B-cell lymphoma. Yang Y; Jin X; Xu M; He W Indian J Ophthalmol; 2024 May; ():. PubMed ID: 38767546 [TBL] [Abstract][Full Text] [Related]
19. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Yamada K; Yamamoto M; Saeki T; Mizushima I; Matsui S; Fujisawa Y; Hara S; Takahashi H; Nomura H; Kawa S; Kawano M Arthritis Res Ther; 2017 Dec; 19(1):262. PubMed ID: 29191210 [TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features. Rasmussen PK Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]